Blood test for clinical therapy guidance of non-small cell lung cancer patients

Projektinformationen

LungCARD

ID Finanzhilfevereinbarung: 734790

DOI 10.3030/734790

Projekt abgeschlossen

EK-Unterschriftsdatum 2 Dezember 2016

Startdatum 1 Januar 2017

Enddatum 31 Oktober 2022

Finanziert unter

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Gesamtkosten € 1 039 500,00

EU-Beitrag € 976 500,00

Koordiniert durch

STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA
Portugal

Leistungen

Documents, reports (4)

Final report on outreach activities (including participation in international events, workshops, seminars and publications)

Final report on outreach activities including participation in international events workshops seminars and publications

Mid-term report on outreach activities (including participation in international events, workshops, seminars and publications)
Report on worldwide research and clinical practices related to Lung cancer pharmacogenomics and therapy
Report on proficiency validation

Websites, patent fillings, videos etc. (1)

Project Website

Veröffentlichungen

Peer reviewed articles (3)

Evaluation of clinical and genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma.

Autoren: Vera Jokic 1, Katarina Savic-Vujovic 2, Jelena Spasic 1, Zoran Bukumiric 3, Mladen Marinkovic 4, Davorin Radosavljevic 1, Milena Cavic 5
Veröffentlicht in: SAGE Journals, Ausgabe 15593258, 2022, ISSN 1559-3258
Herausgeber: International Dose-Response Society
DOI: 10.1177/15593258221117354

Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

Autoren: Jelena Spasic Milena Cavic Nemanja Stanic Bojan Zaric Tomi Kovacevic Davorin Radosavljevic Ljudmila Nagorni-Obradovic
Veröffentlicht in: SAGE Journals, Ausgabe 15593258, 2022, ISSN 1559-3258
Herausgeber: International Dose-Response Society
DOI: 10.1177/15593258221111666

LungCARD - Report on worldwide research and clinical practices related to lung cancer

Autoren: Radmila Jankovic1 , Helena J. Goncalves2 , Milena Cavic1 , Carla Clemente2 , Michael Lind3 , Alexis Murillo Carrasco4 , Selama Nadifi5 , Meriem Khyatti6 , Tumininu Adebambo7 , Dilshod Egamberdiev8 1 Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; 2 StabVida, Caparica, Portugal; 3 University of HULL, UK; 4 Centro de Genética y Biología Molecular, Facultad de Medicina Humana, Uni
Veröffentlicht in: JBUON Open Access Journal aimed at the rapid diffusion of scientific knowledge in Oncology., Ausgabe Bi-monthly, 2019, ISSN 1107-0625
Herausgeber: Zerbinis Medical Publications